Skip to main content
Clinical Trials/NCT01851525
NCT01851525
Completed
Not Applicable

Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

Southlake Regional Health Centre4 sites in 1 country120 target enrollmentStarted: June 2013Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
120
Locations
4
Primary Endpoint
Total cumulative radio frequency (RF) delivery time

Overview

Brief Summary

Catheter ablation has emerged as an effective therapy for atrial fibrillation (AF). However, achievement of complete& durable isolation of the pulmonary veins (PVs) is challenging, primary limited both by operator experience and also the limits of currently available ablation technology. Direct contact force sensing (CFS) is a novel technology that may help to ensure adequate lesion delivery. CFS may also help to improve the safety profile of catheter ablation. The purpose of this study is to compare two strategies of wide antral PV isolation plus linear ablation for persistent AF:

  1. guided by contact force sensing (CFS) OR
  2. blinded to contact force sensing (CFS) - i.e. standard approach

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Total cumulative radio frequency (RF) delivery time

Time Frame: 12 months

Total cumulative RF delivery time for all ablation procedures performed during the study period (12 mo)

Secondary Outcomes

  • Reduction in atrial arrhythmia burden by >90%(12 months)
  • Freedom from AF or atrial arrhythmia >30 sec(12 months)
  • Ability to achieve PV isolation with a single ring of lesions around each PV(6 hours)
  • Ability to achieve linear ablation with complete conduction block on the first attempt(6 hours)
  • Number & location of conduction gaps after initial circumferential ablation lines(6 hours)
  • Number & location of conduction gaps after initial linear ablation(6 hours)
  • Time required for successful PV isolation(12 months)
  • Total fast anatomical mapping (FAM) time(12 months)
  • Time required for successful linear ablation(12 months)
  • FAM volume(12 months)
  • Freedom from ablation-related major adverse events at 90 days post-ablation - specifically perforation, stroke/thromboembolism, esophageal injury, and symptomatic PV stenosis(90 days)
  • Incidence of repeat ablation procedures(12 months)
  • Incidence of conduction gaps around pulmonary veins(12 months)
  • Freedom from atrial arrhythmia > 30 sec(12 months)
  • Freedom from atrial arrhythmia > 30 sec after one or two procedures(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Atul Verma

Principal Investigator

Southlake Regional Health Centre

Study Sites (4)

Loading locations...

Similar Trials